LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 97 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,386,958 | -12.7% | 2,022,846 | +4.3% | 0.00% | – |
Q2 2023 | $2,733,584 | +316.5% | 1,938,712 | +343.1% | 0.00% | – |
Q1 2023 | $656,244 | -35.9% | 437,496 | -50.0% | 0.00% | – |
Q4 2022 | $1,023,740 | +106.0% | 874,992 | +98.8% | 0.00% | – |
Q3 2022 | $497,000 | -28.5% | 440,096 | 0.0% | 0.00% | – |
Q2 2022 | $695,000 | -78.6% | 440,096 | -79.1% | 0.00% | – |
Q1 2022 | $3,242,000 | -36.2% | 2,105,107 | +1.5% | 0.00% | – |
Q4 2021 | $5,082,000 | -63.1% | 2,074,234 | -62.0% | 0.00% | -100.0% |
Q3 2021 | $13,755,000 | +158.4% | 5,458,451 | +192.2% | 0.00% | – |
Q2 2021 | $5,324,000 | +3357.1% | 1,868,046 | +2745.3% | 0.00% | – |
Q1 2021 | $154,000 | +51.0% | 65,654 | +12.9% | 0.00% | – |
Q4 2020 | $102,000 | +88.9% | 58,154 | 0.0% | 0.00% | – |
Q3 2020 | $54,000 | +5.9% | 58,154 | 0.0% | 0.00% | – |
Q2 2020 | $51,000 | -96.5% | 58,154 | -96.7% | 0.00% | – |
Q1 2020 | $1,452,000 | -9.2% | 1,753,991 | -2.4% | 0.00% | – |
Q4 2019 | $1,600,000 | -7.9% | 1,797,923 | +1.4% | 0.00% | – |
Q3 2019 | $1,738,000 | – | 1,773,907 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BROADWOOD CAPITAL INC | 34,935,485 | $55,198,000 | 4.16% |
Raffles Associates | 1,930,536 | $3,050,000 | 3.32% |
Defender Capital, LLC. | 5,131,935 | $8,108,000 | 3.18% |
Prescott General Partners LLC | 1,851,851 | $2,926,000 | 0.20% |
DAFNA Capital Management LLC | 140,000 | $221,000 | 0.06% |
Laurion Capital Management LP | 2,422,367 | $3,827,000 | 0.06% |
Beirne Wealth Consulting Services, LLC | 45,000 | $71,000 | 0.05% |
Fort Sheridan Advisors LLC | 78,931 | $125,000 | 0.04% |
Long Focus Capital Management, LLC | 215,000 | $340,000 | 0.04% |
MORGAN JESS S & CO INC | 20,000 | $32,000 | 0.03% |